Pedro Gaspar

Lisbon, Portugal

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Comment on: Loss of antiphospholipid antibody positivity decreases the risk of recurrent thrombosis in thrombotic antiphospholipid syndrome: reply.

Comment on: Loss of antiphospholipid antibody positivity decreases the risk of recurrent thrombosis in thrombotic antiphospholipid syndrome: reply.

Journal: Rheumatology (Oxford, England)

Published: January 22, 2026

Dysregulation of helper, regulatory, and follicular CD4+ T cells in primary antiphospholipid syndrome: Immunopathology and implications for targeted immunomodulatory therapy.

Dysregulation of helper, regulatory, and follicular CD4+ T cells in primary antiphospholipid syndrome: Immunopathology and implications for targeted immunomodulatory therapy.

Journal: Autoimmunity reviews

Published: January 22, 2026

Delayed diagnosis contributes to increased thrombotic burden and independently predicts severe organ damage in thrombotic antiphospholipid syndrome.

Delayed diagnosis contributes to increased thrombotic burden and independently predicts severe organ damage in thrombotic antiphospholipid syndrome.

Journal: Lupus

Published: November 17, 2025

Loss of antiphospholipid antibody positivity decreases the risk of recurrent thrombosis in thrombotic antiphospholipid syndrome.

Loss of antiphospholipid antibody positivity decreases the risk of recurrent thrombosis in thrombotic antiphospholipid syndrome.

Journal: Rheumatology (Oxford, England)

Published: August 05, 2025

Risk factors for bleeding in patients with thrombotic antiphospholipid syndrome during antithrombotic therapy.

Risk factors for bleeding in patients with thrombotic antiphospholipid syndrome during antithrombotic therapy.

Journal: Lupus

Published: February 20, 2025

Heterogeneity of T follicular regulatory cells: exploring their expanding ontogeny and differentiation pathways.

Heterogeneity of T follicular regulatory cells: exploring their expanding ontogeny and differentiation pathways.

Journal: Immunology and cell biology

Published: February 06, 2025

Damage Index for Antiphospholipid Syndrome (DIAPS): An Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) "Damage" working group report on strengths and limitations.

Damage Index for Antiphospholipid Syndrome (DIAPS): An Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) "Damage" working group report on strengths and limitations.

Journal: Seminars in arthritis and rheumatism

Published: August 14, 2024

Predictors of damage accrual and its impact on health-related quality of life of thrombotic antiphospholipid syndrome: Independent validation of the damage index for antiphospholipid syndrome (DIAPS).

Predictors of damage accrual and its impact on health-related quality of life of thrombotic antiphospholipid syndrome: Independent validation of the damage index for antiphospholipid syndrome (DIAPS).

Journal: Lupus

Published: April 15, 2024

Letter to the Editor Regarding "A Prospective Study of Patients with Persistent Symptoms after SARS-CoV-2 Infection Referred to Physical Medicine and Rehabilitation".

Letter to the Editor Regarding "A Prospective Study of Patients with Persistent Symptoms after SARS-CoV-2 Infection Referred to Physical Medicine and Rehabilitation".

Journal: Acta medica portuguesa

Published: August 20, 2023

Epidemiology of antiphospholipid syndrome: macro- and microvascular manifestations.

Epidemiology of antiphospholipid syndrome: macro- and microvascular manifestations.

Journal: Rheumatology (Oxford, England)

Published: August 16, 2023

Bleeding events in thrombotic antiphospholipid syndrome: prevalence, severity, and associated damage accrual.

Bleeding events in thrombotic antiphospholipid syndrome: prevalence, severity, and associated damage accrual.

Journal: Research and practice in thrombosis and haemostasis

Published: July 23, 2023

Predictors of Long-COVID-19 and its Impact on Quality of Life: Longitudinal Analysis at 3, 6 and 9 Months after Discharge from a Portuguese Centre.

Predictors of Long-COVID-19 and its Impact on Quality of Life: Longitudinal Analysis at 3, 6 and 9 Months after Discharge from a Portuguese Centre.

Journal: Acta medica portuguesa

Published: September 08, 2022

Showing 1-12 of 21

Last Updated: 09/26/2026